Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/1999
11/18/1999CA2331314A1 Anti-diarrheal and method for using the same
11/18/1999CA2331115A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2327549A1 Peptides that induce t cell responses
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957167A1 Production of heterodimeric human fertility hormones
11/17/1999EP0957160A1 Method for inducing immunosuppressive cells and culturing device to be used therefor
11/17/1999EP0956858A1 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/17/1999EP0956360A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
11/17/1999EP0956052A1 Chimeric retrovirus/adenovirus system
11/17/1999EP0956046A2 Cellular vaccines and immunotherapeutics and methods for their preparation
11/17/1999EP0956028A1 Submucosal tissue inhibition of neoplastic cell growth
11/17/1999EP0955995A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
11/17/1999EP0955948A1 Induction of immunological tolerance
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0775008B1 Blood processing device which restricts in flow of whole blood to increase platelet yields
11/17/1999CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections
11/17/1999CN1235551A Pharmaceutical composition for diabetes
11/17/1999CN1235054A Therapeutic agent for ischemic diseases
11/17/1999CN1235050A Prescription of Tongluofutanwan as medicine for activating collaterals and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235049A Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis and preparing method thereof
11/17/1999CN1235048A Prescription of Tongshuanhuoluowan as medicine for thrombolysis and activating collaterals and preparing method thereof
11/17/1999CN1235047A Prescription of Tongshuanjiangyawan as hypotensor and thrombolytic medicine and preparing method thereof
11/17/1999CN1235043A Powder for relieving cough and asthma
11/17/1999CN1235042A Chinese medicinal composition for sores and erythra
11/17/1999CN1235035A Medicine and prescription for toxoplasmic disease
11/17/1999CN1235029A Medicine for regulating menstruation and arresting bleeding and producing process therefor
11/17/1999CN1235028A Chinese medicine for argiitis
11/17/1999CN1235027A Micro-capsuled pheochromocyte of bull adrenal medulla as medicine for curing pains
11/17/1999CN1235026A Preparing method for injection of placenta peptide and products thereof
11/17/1999CN1235025A Injection of thyrotrophin releasing hormone
11/17/1999CN1046421C Drug for curing pulmonary tuberculosis
11/17/1999CN1046420C Prescription for external use medicine for curing many kinds of diseases
11/17/1999CN1046418C Spray for burn and scald and preparing method thereof
11/17/1999CN1046416C Instant medicine for chyluria
11/17/1999CN1046412C Bone marrow purifying preparation and preparing method thereof
11/16/1999US5986170 Murine model for human carcinoma
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986043 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
11/16/1999US5985839 Treating cancer, psoriasis, acne
11/16/1999US5985837 Cell growth inhibitor peptides; treating cancer in a mammal
11/16/1999US5985824 By mobilizing mutant forms of cftr (cystic fibrosis transmembrane conductance regulator) to the plasma membrane where they can mediate chloride ion transport by administering deoxyspergualin
11/16/1999US5985660 Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
11/16/1999US5985656 Human cell line comprising, double negative suppressor cells characterized by specific surface marker pattern, which inhibit the mixed lymphocyte reaction in vitro, but do not kill corresponding target cells; density gradient separation
11/16/1999US5985655 Retroviral vector particle containing a chimeric envelope includes a receptor binding region that binds to a receptor of a target cell; a portion of the envelope gene deleted and replaced with another receptor binding region or ligand
11/16/1999US5985611 Culturing animal cells; transformation with gene expression; recovering
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985539 Method of reconstructing animal organs
11/16/1999US5985333 Pharmaceutical formulation containing a DNA-sodium salt for burn and wound treatment
11/16/1999US5985332 Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
11/16/1999US5985330 Administering body wall, epithelial layer, or flower; antitumor agents; rheumatoid arthritis treatment
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985270 Antitumor
11/16/1999CA2066761C Cell separation invention
11/11/1999WO1999057304A1 Bacteriophage assay
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057248A1 Induction of neuronal regeneration
11/11/1999WO1999056785A2 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction
11/11/1999WO1999056773A2 Composition comprising tumor cells and extracts and method of using thereof
11/11/1999WO1999056762A1 Preventives and ameliorating agents for periodontosis
11/11/1999WO1999056759A1 Bone marrow cells as a source of neurons for brain and spinal cord repair
11/11/1999WO1999056758A1 A food composition and method of using same
11/11/1999WO1999056753A1 Hematopoietic stimulation
11/11/1999WO1999056535A1 Culture of sessile marine animals
11/11/1999WO1999044582A3 Nontoxic vernix compositions and method of producing
11/11/1999WO1999043786A3 Submucosa gel compositions
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999CA2331122A1 Hematopoietic stimulation
11/11/1999CA2330814A1 Bacteriophage assay
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/10/1999EP0955545A1 Process to select bacterial strains
11/10/1999EP0955359A1 Method for introducing genetic material into a cell
11/10/1999EP0954594A2 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954565A1 Adipogenic differentiation of human mesenchymal stem cells
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954374A1 Methods and devices for the reduction of small organic compounds from blood products
11/10/1999EP0954336A2 Membrane incorporation of texaphyrins
11/10/1999EP0954326A1 A process for viral inactivation of lyophilized blood proteins
11/10/1999EP0954325A1 Method for the specific immunoadsorption of selected pathogenic factors
11/10/1999EP0954279A2 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid
11/10/1999CN1234835A Gene therapy for congestive heart failure
11/10/1999CN1234740A Process to obtain oestrogens from mare's urine
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234276A Process for producing transfer factors resisting virus of respiratory tract
11/10/1999CN1234274A Medicine for treatment of myopia
11/10/1999CN1234271A Capsule for treatment of rheumatic angitis and its preparation method
11/10/1999CN1234270A Pancreas-recovering thirst-relieving and blood-sugar reducing powder, and preparing method thereof
11/10/1999CN1234267A Anrutong capsule for treatment of mammary-gland disease
11/10/1999CN1234253A Health-care drink of nourishing spleen and kidney
11/10/1999CN1234241A Chinese-medicine mixture for treatment of diabetes
11/10/1999CN1234239A Sprayed powder for treating macerative erosive beriberi
11/10/1999CN1234235A Chinese medicine capsule for treating lumbar and cervical protrusion
11/10/1999CN1234226A Mite-killing face-beauty cream